ASH 2023 | EMN26 clinical trial
Channel: Myeloma Patients Europe
Date: 15/12/2023

Prof. Pieter Sonneveld, Professor of Haematology and Head of the Department of Haematology at the Erasmus MC Cancer Institute and Professor of Haematology at the Erasmus University of Rotterdam, The Netherlands, explains the main results of the EMN26 Study: iberdomide maintenance after autologous stem-cell tTransplantation.